Related Experiment Videos

Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins

Kristin O'Neil-Callahan1, George Katsimaglis, Micah R Tepper

  • 1Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Journal of the American College of Cardiology
|February 1, 2005
PubMed

Insights

Statins significantly reduced cardiac complications, including ischemia and heart failure, in patients undergoing vascular surgery. This protective effect was observed even after accounting for other risk factors, highlighting statins

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Pharmacology

Background:

  • Cardiovascular complications are a significant cause of morbidity in patients undergoing noncardiac surgery.
  • Statins are known to reduce cardiac morbidity and mortality in patients with coronary disease.
  • The early beneficial effects of statins are independent of their lipid-lowering or plaque-stabilizing properties.

Purpose of the Study:

  • To evaluate the efficacy of statins in decreasing cardiac complications in patients undergoing noncardiac vascular surgery.
  • To identify medications that may offer a protective effect against perioperative cardiac complications.

Main Methods:

  • Retrospective analysis of 1,163 patients undergoing carotid endarterectomy, aortic surgery, or lower extremity revascularization between January 1999 and December 2000.
  • Data collected included patient characteristics, medical history, admission medications, and perioperative outcomes (death, myocardial infarction, ischemia, congestive heart failure, ventricular tachyarrhythmias).
  • Univariate and multivariate logistic regression analyses were used to identify predictors of complications and protective medications.

Main Results:

  • Cardiac complications occurred in 9.9% of patients receiving statins versus 16.5% of those not receiving statins (p = 0.001).
  • The reduction in complications was primarily due to fewer instances of myocardial ischemia and congestive heart failure.
  • Statins demonstrated a significant protective effect (odds ratio 0.52, p = 0.001) after adjusting for other risk factors, including age, gender, surgery type, emergent status, left ventricular dysfunction, and diabetes mellitus.

Conclusions:

  • Statins were found to be highly protective against perioperative cardiac complications in patients undergoing vascular surgery.
  • The protective benefits of statins were consistent across various patient subgroups.
  • The study suggests that statin use is a valuable strategy for mitigating cardiac risk in this patient population.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...